Clinical Trial Update: Pilot Herniorrhaphy Study for Postoperative Analgesia [Phase 2]

View source ↗

Summary

A Phase 2 pilot study by Heron Therapeutics evaluated Zynrelef (HTX-011) for postoperative analgesia after herniorrhaphy; the trial has completed and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• ZYNRELEF (BUPIVACAINE AND MELOXICAM)

Snippet

Sponsor: Heron Therapeutics | Conditions: Postoperative Pain | Phase 2 | Status: COMPLETED | Results posted: 2023-10-04